Spots Global Cancer Trial Database for adult papillary meningioma

Every month we try and update this database with for adult papillary meningioma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Changes in Semen or Sperm Caused by Temozolomide in Patients With Newly Diagnosed, Progressive, or Recurrent Primary Malignant Brain Tumors	NCT00499798	Brain and Centr... Chemotherapeuti... Infertility		18 Years - 60 Years	Wake Forest University Health Sciences
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors	NCT00002647	Brain and Centr... Metastatic Canc...	verteporfin conventional su...	3 Years - 70 Years	National Cancer Institute (NCI)
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma	NCT00348790	Brain and Centr... Sarcoma	vatalanib	18 Years -	Northwestern University
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma	NCT01119599	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Primary M... Adult Subependy... Adult Subependy... Adult Supratent... Malignant Adult...	3-Dimensional C... Gamma-Secretase... Intensity-Modul... Laboratory Biom... Pharmacological... Temozolomide Therapeutic Con...	19 Years -	National Cancer Institute (NCI)
Study of Tissue Samples From Patients With Glioma or Other Brain Tumors	NCT00967200	Central Nervous...	laboratory biom... pharmacogenomic...	18 Years - 120 Years	University Hospital, Montpellier
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	NCT00895622	Brain and Centr...	54 Gy radiother... 60 Gy radiother...	18 Years -	Radiation Therapy Oncology Group
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma	NCT00904735	Brain and Centr...	hydroxyurea imatinib mesyla...	18 Years - 75 Years	National Cancer Institute (NCI)
Vatalanib in Treating Patients With Recurrent or Progressive Meningioma	NCT00348790	Brain and Centr... Sarcoma	vatalanib	18 Years -	Northwestern University
Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma	NCT00904735	Brain and Centr...	hydroxyurea imatinib mesyla...	18 Years - 75 Years	National Cancer Institute (NCI)
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	NCT01125046	Acoustic Schwan... Adult Anaplasti... Adult Ependymom... Adult Grade I M... Adult Grade II ... Adult Meningeal... Adult Papillary... Neurofibromatos... Neurofibromatos... Recurrent Adult...	bevacizumab	18 Years -	Northwestern University
Stress Reduction Program in Patients With Malignant Brain Tumors and Their Family Caregivers	NCT00376818	Brain and Centr... Psychosocial Ef...	exercise interv... educational int... physiologic tes... management of t... mind-body inter... Measurement of ...	18 Years -	Case Comprehensive Cancer Center
Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders	NCT00255671	Brain and Centr... Metastatic Canc... Radiation Toxic...	Questionnaire	18 Years -	Case Comprehensive Cancer Center
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases	NCT02967380	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Primary M... Adult Supratent... Malignant Adult... Metastatic Mali... Multiple Sclero... Recurrent Adult...	Dynamic Contras... Gadobenate Dime... Gadobutrol Gadopentetate D...	18 Years -	University of Southern California
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	NCT01125046	Acoustic Schwan... Adult Anaplasti... Adult Ependymom... Adult Grade I M... Adult Grade II ... Adult Meningeal... Adult Papillary... Neurofibromatos... Neurofibromatos... Recurrent Adult...	bevacizumab	18 Years -	Northwestern University
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors	NCT00629889	Brain and Centr... Seizure	levetiracetam pregabalin	18 Years -	Centre Hospitalier Universitaire Vaudois
Yoga Therapy in Treating Patients With Malignant Brain Tumors	NCT01234805	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Supratent... Recurrent Adult...	yoga therapy questionnaire a... quality-of-life...	18 Years -	Wake Forest University Health Sciences
Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment	NCT00544284	Brain and Centr... Lymphoma Metastatic Canc... Unspecified Adu...	bortezomib temozolomide pharmacological...	18 Years -	City of Hope Medical Center
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors	NCT02194452	Acoustic Schwan... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Choroid P... Adult Craniopha... Adult Diffuse A... Adult Ependymob... Adult Ependymom... Adult Giant Cel... Adult Glioblast... Adult Gliosarco... Adult Grade I M... Adult Grade II ... Adult Medullobl... Adult Meningeal... Adult Mixed Gli... Adult Myxopapil... Adult Oligodend... Adult Papillary... Adult Pilocytic... Adult Pineal Gl... Adult Pineoblas... Adult Pineocyto... Adult Subependy... Adult Subependy... Adult Supratent... Childhood Choro... Childhood Crani... Childhood Epend... Childhood Grade... Childhood Grade... Childhood Grade... Childhood High-... Childhood High-... Childhood Infra... Childhood Low-g... Childhood Low-g... Childhood Medul... Childhood Supra... Meningeal Melan... Newly Diagnosed... Recurrent Adult... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Recurrent Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child... Untreated Child...	gallium Ga 68-e... positron emissi... computed tomogr... laboratory biom...	6 Months - 29 Years	University of Iowa
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	NCT00492089	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Grade III... Adult Malignant... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineocyto... Malignant Neopl... Meningeal Melan... Radiation Toxic... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	bevacizumab placebo magnetic resona... quality-of-life...	18 Years -	National Cancer Institute (NCI)
Levetiracetam or Pregabalin in Treating Seizures in Patients Undergoing Chemotherapy and/or Radiation Therapy For Primary Brain Tumors	NCT00629889	Brain and Centr... Seizure	levetiracetam pregabalin	18 Years -	Centre Hospitalier Universitaire Vaudois
Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive Meningioma	NCT00354913	Glioblastoma Gliosarcoma	hydroxyurea imatinib mesyla...	18 Years -	Duke University
Bevacizumab in Treating Patients With Recurrent or Progressive Meningiomas	NCT01125046	Acoustic Schwan... Adult Anaplasti... Adult Ependymom... Adult Grade I M... Adult Grade II ... Adult Meningeal... Adult Papillary... Neurofibromatos... Neurofibromatos... Recurrent Adult...	bevacizumab	18 Years -	Northwestern University
Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma	NCT00895622	Brain and Centr...	54 Gy radiother... 60 Gy radiother...	18 Years -	Radiation Therapy Oncology Group
Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer	NCT00492089	Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Anaplasti... Adult Brain Ste... Adult Central N... Adult Choroid P... Adult Diffuse A... Adult Ependymom... Adult Grade II ... Adult Grade III... Adult Malignant... Adult Mixed Gli... Adult Oligodend... Adult Papillary... Adult Pineocyto... Malignant Neopl... Meningeal Melan... Radiation Toxic... Recurrent Adeno... Recurrent Adult... Recurrent Basal... Recurrent Esthe... Recurrent Inver... Recurrent Lymph... Recurrent Lymph... Recurrent Midli... Recurrent Mucoe... Recurrent Saliv... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Squam... Recurrent Verru... Recurrent Verru... Stage I Adenoid... Stage I Basal C... Stage I Esthesi... Stage I Inverte... Stage I Lymphoe... Stage I Lymphoe... Stage I Midline... Stage I Mucoepi... Stage I Salivar... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Squamou... Stage I Verruco... Stage I Verruco... Stage III Adeno... Stage III Basal... Stage III Esthe... Stage III Inver... Stage III Lymph... Stage III Midli... Stage III Mucoe... Stage III Saliv... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Squam... Stage III Verru... Stage III Verru... Stage IV Adenoi... Stage IV Basal ... Stage IV Esthes... Stage IV Invert... Stage IV Lympho... Stage IV Lympho... Stage IV Midlin... Stage IV Mucoep... Stage IV Saliva... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Squamo... Stage IV Verruc... Stage IV Verruc...	bevacizumab placebo magnetic resona... quality-of-life...	18 Years -	National Cancer Institute (NCI)

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: